GPP
OFIX icon

Great Point Partners’s Orthofix Medical OFIX Stock Holding History

Great Point Partners’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-265,000
Closed -$7.99M – 43
2014
Q1 		$7.99M Buy
+265,000
New +$6.11M 4.17% 8

Other funds holding OFIX

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Great Point Partners's OFIX Position: Q2 2015 in Review

Great Point Partners sold out of Orthofix Medical (OFIX) in Q2 2015, closing a stake of 300,000 shares — an estimated $10.8M sold.

Great Point Partners first reported a position in OFIX in Q1 2014 and held it in 5 quarters. The position peaked at $10.9M in Q2 2014. 110 funds tracked by Wall St. Rank hold OFIX as of Q2 2015.

  • Great Point Partners reported no remaining Orthofix Medical position as of Q2 2015 after selling out during the quarter.
  • Great Point Partners sold 300,000 Orthofix Medical shares in Q2 2015, an estimated $10.8M.
  • Great Point Partners first reported a position in Orthofix Medical in Q1 2014 and held it in 5 quarters.
  • Great Point Partners's Orthofix Medical position peaked at $10.9M in Q2 2014.
  • 110 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2015.

Based on Great Point Partners's 13F filing for Q2 2015, filed 14 Aug 2015.